Lupin peaked at Rs 2,312 on September 5, 2024, but lost momentum, breaching key moving averages on daily charts. A buy signal from the Supertrend indicator on December 23, 2024, boosted bullish sentiment. After bottoming near Rs 2,000 in November, aligning with the 30-week SMA on weekly charts, the pharma stock rebounded strongly, regaining crucial short-term moving averages.
